Title(s): Associate Professor of Microbiology and Immunology
Department(s): Microbiology and Immunology
Education: University of Cambridge, U.K., Ph.D., 1997 University of Cambridge, U.K., BA 1994
Dr. Usherwood received his B.A. in 1990 in Natural Sciences from the University of Cambridge, U.K. He continued his studies at the University of Cambridge and was awarded his Ph.D. from the Department of Pathology in 1994. From 1994 to 1997 Dr. Usherwood undertook postdoctoral research at the University of Edinburgh, U.K. then he moved to Memphis, TN for further postdoctoral work in the Department of Immunology at St. Jude's Children's Research Hospital. From 1999 to 2001 he held a position as a Research Assistant Member at The Trudeau Institute, NY. He came to Dartmouth in 2001 as an Assistant Professor, then was promoted to Associate Professor in 2007.
Programs: Immunology Program Molecular and Cellular Biology Graduate Programs Molecular Pathogenesis Program Norris Cotton Cancer Center
Zhang W, Zhang T, Turk MJ, Usherwood EJ A persistent virus vector confers superior anti-tumor immunity, compared with a non-persistent vector. Cancer Immunol Immunother 2009 Nov 17; (): PMID: 19921188 [PubMed - as supplied by publisher]
Fuse S, Molloy MJ, Usherwood EJ Immune responses against persistent viral infections: possible avenues for immunotherapeutic interventions. Crit Rev Immunol 2008; 28(2):159-83 PMID: 18540829 [PubMed - indexed for MEDLINE]
Cote AL, Usherwood EJ, Turk MJ Tumor-specific T-cell memory: clearing the regulatory T-cell hurdle. Cancer Res 2008 Mar 15; 68(6):1614-7 PMID: 18339838 [PubMed - indexed for MEDLINE]
Fuse S, Zhang W, Usherwood EJ Control of memory CD8+ T cell differentiation by CD80/CD86-CD28 costimulation and restoration by IL-2 during the recall response. J Immunol 2008 Jan 15; 180(2):1148-57 PMID: 18178855 [PubMed - indexed for MEDLINE]
Fuse S, Usherwood E Simultaneous analysis of in vivo CD8+ T cell cytotoxicity against multiple epitopes using multicolor flow cytometry. Immunol Invest 2007; 36(5-6):829-45 PMID: 18161531 [PubMed - indexed for MEDLINE]
Zhang P, Cote AL, de Vries VC, Usherwood EJ, Turk MJ Induction of postsurgical tumor immunity and T-cell memory by a poorly immunogenic tumor. Cancer Res 2007 Jul 1; 67(13):6468-76 PMID: 17616708 [PubMed - indexed for MEDLINE]
Professional Interests:
Dr Usherwood studies the generation and maintenance of T cell memory. T cells recognized and destroy cells infected with intracellular pathogens such as viruses and are also important in protection against tumor development . A large expansion in the number of virus-specific T cells occurs shortly after virus infection, however most of these cells die after virus clearance has been accomplished. A small residual population of T cells then persists lifelong and forms the basis of immunological memory. Using techniques such as MHC/peptide tetramer staining we can identify these memory cells and interrogate their functional capabilities under different conditions. Our work has shown that costimulation and CD4 T cell help have dramatic effects both on the resting memory population and their ability to mount secondary immune response. We have devised several methods to restore the functional defects present in these cells, and these may represent important new immunotherapies.
Another major area of interest in the lab is the impact upon the memory response of a persistent virus infection. We use the murine gammaherpesvirus model system, which represents a low-load persistent virus infection. This virus is also a model for the human gammaherpesviruses, which are significant causes of malignancy and other disease in immunosuppressed patients. Therefore this work has significance both for our understanding of the memory T cell response in general and more specifically how the gammaherpesviruses are controlled, in addition to how and why this control breaks down. Our research has shown several distinct changes occur in the memory response during persistent infection. In models where immune surveillance breaks down we are studying the underlying mechanisms for this breakdown, and developing immune therapies to restore immune surveillance to the virus.
Courses Taught:
Medical Virology (Medical School)
Immune Therapy Advanced Course (MCB graduate program)
MCB graduate program core course
Grant Information:
NCI R01 "Immune surveillance in murine gammaherpesvirus infection"
NIAID R01 "T cell function in murine gammaherpesvirus infection"